Dal Alert!

Receive alerts from Dalhousie by text message.


Drug Policy

Select item 22479042 [ ]1.

Coping strategies used by patients infected with hepatitis C virus who are facing medication costs.

Sanyal C, Ingram EL, Sketris IS, Peltekian KM, Kirkland S.

Can J Hosp Pharm. 2011 Mar;64(2):131-40.



Survey instrument is attached.

Groves KEM, Schellinck T, Sketris I, MacKinnon N. Identifying early prescribers of cycloxygenase-2 inhibitors (COX-2s) in Nova Scotia, Canada: Considerations for targeted academic detailing.  [PDF - 169 kB]Research in Social and Administrative Pharmacy. 2009.
Ackroyd-Stolarz S, MacKinnon NJ, Sketris I, Sabo B. Potentially Inappropriate
Prescribing of Benzodiazepines for Older Adults and Risk of Falls During a
Hospital Stay: A Descriptive Study. [PDF - 174 kB] Canadian Journal of Hospital Pharmacy.
2009; 62(4): 276-83.
The National Pharmaceuticals Strategy: Rest in peace, revive or renew? [PDF - 158 kB]MacKinnon NJ, Ip I. Canadian Medical Association Journal. 2009; 180(8): 801-3.
Impact of drug plan management policies in Canada: A systematic review. [PDF - 303 kB]Morrison A, MacKinnon NJ, Hartnell NR, McCaffrey KJ. Canadian Pharmacists Journal. 2008; 141(6): 332-338.  
Medication Management: Perceptions and Opinions of Canadian Hospital Executives. [PDF - 346 kB]Neil J MacKinnon, Nicole R Hartnell, Colleen J Metge, Ingrid Sketris, and Jean-François Bussières C JHP – Vol. 61, No. 1 – January–February 2008
Provincial drug plans: now there’s a minefield Data on provincial differences adds important perspective. [PDF - 266 kB]Neil J. MacKinnon CPJ/RPC • SEPTEMBER 2004, VOL. 137, NO. 7